Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Aroa Biosurgery Ltd ( (AU:ARX) ) has issued an announcement.
Aroa Biosurgery Ltd has announced a change in the director’s interest, specifically involving the lapse of options due to expiry. This change reflects a reduction in the number of options held by Director James McLean, which may impact his financial stake in the company but does not affect the overall number of fully paid ordinary shares he holds. Such changes are routine and part of the company’s regulatory compliance, with no immediate implications for stakeholders or the company’s market position.
The most recent analyst rating on (AU:ARX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on Aroa Biosurgery Ltd stock, see the AU:ARX Stock Forecast page.
More about Aroa Biosurgery Ltd
Aroa Biosurgery Ltd operates in the medical technology industry, focusing on the development and production of regenerative tissue products. The company is known for its innovative solutions that aid in tissue repair and healing, primarily targeting the healthcare sector.
Average Trading Volume: 233,663
Technical Sentiment Signal: Buy
Current Market Cap: A$203.6M
For an in-depth examination of ARX stock, go to TipRanks’ Overview page.